Trials / Completed
CompletedNCT05339334
A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.
A Phase 1, Single Center, Open-label Study of PF-07321332 Administrated as Multiple Oral Doses in Healthy Chinese Participants.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this Phase 1 clinical trial is to help us understand how the drug is changed and eliminated from your body after you take it, the safety, and the the extent to which dise effects can be tolerated of PF-07321332 when PF-07321332 and ritonavir are given to healthy adult Chinese participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-07321332/ritonavir | PF-07321332/ritonavir will be given by mouth two times a day for 10 days |
Timeline
- Start date
- 2022-03-10
- Primary completion
- 2022-04-21
- Completion
- 2022-04-21
- First posted
- 2022-04-21
- Last updated
- 2024-10-08
- Results posted
- 2024-10-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05339334. Inclusion in this directory is not an endorsement.